There are 2789 resources available
1134P - Personalized medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction
Presenter: Paweł Zawadzki
Session: ePoster Display
1135P - Impact of MCED screening interval on reduction in late-stage cancer diagnosis and mortality
Presenter: Peter Sasieni
Session: ePoster Display
1136P - A clinically applicable cervical cancer artificial intelligence screening system for accurate cytopathological diagnosis: A multicenter population-based study and randomized controlled trial
Presenter: Yunfang Yu
Session: ePoster Display
Resources:
Abstract
1137P - Machine learning radiomics for prediction of survival in non-small cell lung cancer patients studied with PET/CT and FDG
Presenter: Andrea Ciarmiello
Session: ePoster Display
1139P - Carcinoma of unknown primary (CUP): The role of tumor genomic profiling
Presenter: Cathleen Park
Session: ePoster Display
1092TiP - Investigational (Inv) agents with or without pembrolizumab (pembro) or pembro alone in melanoma (mel): KEYMAKER-U02
Presenter: Reinhard Dummer
Session: ePoster Display
1093TiP - An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]
Presenter: Francesca Aroldi
Session: ePoster Display
1094TiP - A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]
Presenter: Andrew Haydon
Session: ePoster Display